Brandinium

Trademark search for:

MEDCLUE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-08-30 — Application filed
  • 2016-09-03 — Application filed
  • 2016-09-06 — Notice of pseudo mark e-mailed
  • 2016-12-08 — Assigned to examiner
  • 2016-12-09 — Final disposition recorded
  • 2016-12-09 — Final disposition recorded
  • 2016-12-09 — Final disposition recorded
  • 2017-01-10 — Teas/email correspondence entered
  • 2017-01-10 — Office action issued
  • 2017-01-10 — Correspondence received in law office
  • 2017-01-11 — Approved for pub - principal register
  • 2017-02-01 — Notification of notice of publication e-mailed
  • 2017-02-21 — Published for opposition
  • 2017-02-21 — Official gazette publication confirmation e-mailed
  • 2017-04-18 — Noa e-mailed - sou required from applicant
  • 2017-09-14 — Teas statement of use received
  • 2017-09-14 — Sou teas extension received
  • 2017-09-14 — Sou extension 1 filed
  • 2017-09-14 — Use amendment filed
  • 2017-09-26 — Case assigned to intent to use paralegal
  • 2017-09-27 — Office action issued
  • 2017-09-27 — Sou extension 1 granted
  • 2017-09-28 — Notice of approval of extension request e-mailed
  • 2017-10-04 — Office action issued
  • 2017-11-01 — Office action issued
  • 2017-11-28 — Office action issued
  • 2017-11-28 — Office action issued
  • 2018-01-18 — Statement of use processing complete
  • 2018-02-05 — Final disposition recorded
  • 2018-02-05 — Final disposition recorded
  • 2018-02-05 — Final disposition recorded
  • 2018-04-18 — Office action issued
  • 2018-04-26 — Assigned to lie
  • 2018-04-26 — Correspondence received in law office
  • 2018-04-26 — Teas/email correspondence entered
  • 2018-04-27 — Allowed principal register - sou accepted
  • 2018-04-28 — Notice of acceptance of statement of use e-mailed
  • 2018-04-30 — Teas change of correspondence received
  • 2018-05-02 — Teas withdrawal of attorney received-firm retains
  • 2018-06-05 — Registered-principal register
  • 2019-04-22 — Teas revoke/app/change addr of atty/dom rep received
  • 2019-04-22 — Attorney/dom.rep.revoked and/or appointed
  • 2023-06-05 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2023-09-27 — Applicant/correspondence changes (non-responsive) entered
  • 2023-09-27 — Teas change of owner address received
  • 2023-09-27 — Attorney/dom.rep.revoked and/or appointed
  • 2023-09-27 — Teas change of correspondence received
  • 2023-09-27 — Teas revoke/app/change addr of atty/dom rep received
  • 2023-10-04 — Teas change of correspondence received
  • 2023-10-04 — Attorney/dom.rep.revoked and/or appointed
  • 2023-10-04 — Teas change of owner address received
  • 2023-10-04 — Teas revoke/app/change addr of atty/dom rep received
  • 2023-10-04 — Applicant/correspondence changes (non-responsive) entered
  • 2024-12-20 — Cancelled sec. 8 (6-yr)
  • 2024-12-20 — Final status recorded

Owner Information

NorthShore University HealthSystem
Warrenville , IL
NorthShore University HealthSystem
Evanston , IL
NorthShore University HealthSystem
Evanston , IL

Correspondent

Andrew L. Goldstein Smith, Gambrell & Russell LLP
311 S. Wacker Drive
Suite 3000
Chicago, IL 60606

Filing Details

Filing Date:
2016-08-30
Status Date:
2024-12-20
Category:
Pharmaceuticals
Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.